DRAVET SYNDROME
Clinical trials for DRAVET SYNDROME explained in plain language.
Never miss a new study
Get alerted when new DRAVET SYNDROME trials appear
Sign up with your email to follow new studies for DRAVET SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Hope for Hard-to-Treat seizures: Long-Term drug safety confirmed
Disease control CompletedThis study aimed to understand the long-term safety of a medication called ZX008 (fenfluramine) when used alongside other treatments for severe, rare seizure disorders like Dravet and Lennox-Gastaut syndromes. It involved 412 patients who had already benefited from the drug in ea…
Matched conditions: DRAVET SYNDROME
Phase: PHASE3 • Sponsor: Zogenix, Inc. • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
New hope for controlling devastating childhood epilepsies
Disease control CompletedThis study tested the long-term safety of an add-on epilepsy drug called LP352 for people with severe, hard-to-treat epilepsies like Dravet and Lennox-Gastaut syndromes. It followed 41 participants for up to a year to see if the drug was safe to take continuously and if it helped…
Matched conditions: DRAVET SYNDROME
Phase: PHASE2 • Sponsor: Longboard Pharmaceuticals • Aim: Disease control
Last updated Feb 18, 2026 14:07 UTC
-
Scientists test Easier-to-Swallow liquid for severe childhood epilepsy
Knowledge-focused CompletedThis study tested how the body absorbs a new liquid form of the drug stiripentol, used for a severe form of childhood epilepsy called Dravet syndrome. Researchers compared it to the standard capsule form in 24 healthy adults to see if they work similarly. The goal is to provide a…
Matched conditions: DRAVET SYNDROME
Phase: PHASE1 • Sponsor: Biocodex • Aim: Knowledge-focused
Last updated Mar 16, 2026 15:24 UTC